HealthCare Global Enterprises Limited (HCG) announced its unaudited financial results for the first quarter of FY27, ending June 30, 2026. The company reported a consolidated revenue of ₹6,951 Mn, marking a 13% year-over-year increase. Adjusted EBITDA also saw a significant rise of 20% to ₹1,339 Mn, with margins improving to 19.4% from 18.2% in Q1 FY26.
HealthCare Global Enterprises Reports Strong Q1 FY27 Performance
HealthCare Global Enterprises Limited (HCG) has announced its unaudited financial results for the first quarter of the financial year 2027 (Q1 FY27), which concluded on June 30, 2026. The Board of Directors approved these results in a meeting held on August 6, 2026.
Key Financial Highlights:
Revenue Growth
HCG delivered a consolidated revenue of ₹6,951 Mn in Q1 FY27, representing a robust 13% growth compared to the same period last year. This broad-based growth was driven by an 11% increase in volume and a 2% rise in Average Realization Per Patient (ARPP). The company highlighted that revenue growth was particularly strong in the South (+16%) and East (+22%) regions.
EBITDA and Profitability
Adjusted EBITDA for Q1 FY27 stood at ₹1,339 Mn, an increase of 20% year-over-year. The Adjusted EBITDA margin improved to 19.4% from 18.2% in Q1 FY26, reflecting enhanced operational efficiency and quality of revenue. Profit after tax (PAT) for the quarter was ₹137.7 Mn, a substantial 190% increase from the previous year, with an Adj. PAT Margin of 2.0%.
Operational Performance:
Operational highlights include a 11% year-over-year increase in Volume to 78,914. ARPP saw a 2% growth to ₹85,943. The Non-Institutional Mix improved by 189 bps, and Operational Beds saw an addition of 121 beds quarter-on-quarter.
Key Business Developments:
- The North Bangalore facility commenced operations in May 2026, adding 56 beds and generating ₹67 million in revenue in its first quarter. The facility also commissioned an MR Linac in July 2026.
- HCG added a total of 121 operational beds across various locations, including North Bangalore, Ranchi, Borivali, Nashik, Hubli, and Kenya.
- The Rajkot facility was upgraded with a new LINAC, transforming it into a Comprehensive Cancer Care (CCC) Centre.
- Robotic surgery capabilities were strengthened with the addition of new robotic systems at Nashik and replacement at Bangalore CoE.
Strategic Priorities:
The company’s strategic priorities focus on optimizing its existing network, improving network efficiency, investing in growth through brownfield expansion and strengthening market presence, and enhancing the patient experience through infrastructure upgrades and digital technology.
The Investor Presentation detailing these results is available on the company’s website at https://www.hcgoncology.com/investor-relations/.
Source: BSE
